BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31570954)

  • 1. Effects of Social Disparities on Management and Surgical Outcomes for Patients with Secondary Hyperparathyroidism.
    Greene B; Kim SJ; McCarthy EP; Pasternak JD
    World J Surg; 2020 Feb; 44(2):537-543. PubMed ID: 31570954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States.
    Kim SM; Long J; Montez-Rath ME; Leonard MB; Norton JA; Chertow GM
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1260-1267. PubMed ID: 27269300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial Disparities in Primary Hyperparathyroidism.
    Fieber J; Goodsell K; Kelz RR; Ermer JP; Wirtalla C; Fraker DL; Wachtel H
    World J Surg; 2021 Jan; 45(1):180-187. PubMed ID: 32978665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data to inform counseling on parathyroidectomy for secondary hyperparathyroidism of renal origin.
    Williams-Karnesky RL; Krumeich L; Wachtel H; Fraker DL; Wirtalla C; Venuto FA; Sellers P; Kelz RR
    Surgery; 2022 Jan; 171(1):63-68. PubMed ID: 34497026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing Surgical Management of Secondary Hyperparathyroidism in the United States.
    Fligor SC; Li C; Hamaguchi R; William J; James BC
    J Surg Res; 2021 Aug; 264():444-453. PubMed ID: 33848844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Black patients are more likely to undergo parathyroidectomy for secondary hyperparathyroidism.
    Udyavar NR; Ahn J; Crepeau P; Morris-Wiseman LF; Thompson V; Chen Y; Segev DL; McAdams-DeMarco M; Mathur A
    Surgery; 2023 Jan; 173(1):111-116. PubMed ID: 36195501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroidectomy in dialysis patients.
    Kuo LE; Wachtel H; Karakousis G; Fraker D; Kelz R
    J Surg Res; 2014 Aug; 190(2):554-8. PubMed ID: 24950795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and disparities in parathyroidectomy for symptomatic primary hyperparathyroidism in the Medicare population.
    Herb J; Staley BS; Roberson M; Strassle PD; Kim LT
    Surgery; 2021 Nov; 170(5):1376-1382. PubMed ID: 34127301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in patients with renal hyperparathyroidism requiring cinacalcet pre-operatively followed by parathyroidectomy.
    Baker D; Sevak S; Callahan RE; Czako PF; Lloyd LR; Nagar S
    Am J Surg; 2019 Jan; 217(1):146-151. PubMed ID: 29929906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons.
    Mallick R; Xie R; Kirklin JK; Chen H; Balentine CJ
    Ann Surg Oncol; 2021 Jan; 28(1):476-483. PubMed ID: 32542566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of parathyroidectomy in renal hyperparathyroidism in patients with No access to renal transplantation in Singapore.
    Rajeev P; Lee KY; Tang XJ; Goo TT; Tan WB; Ngiam KY
    Int J Surg; 2016 Jan; 25():64-8. PubMed ID: 26612524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does race impact outcomes after parathyroidectomy for secondary and tertiary hyperparathyroidism?
    Green RL; Fagenson AM; Karhadkar SS; Kuo LE
    Am J Surg; 2023 Nov; 226(5):652-659. PubMed ID: 37453804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons' Society of Japan.
    Tominaga Y; Kakuta T; Yasunaga C; Nakamura M; Kadokura Y; Tahara H
    Ther Apher Dial; 2016 Feb; 20(1):6-11. PubMed ID: 26879490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of parathyroidectomy versus cinacalcet in the clinical management of secondary hyperparathyroidism.
    Kim WW; Rhee Y; Kim BS; Kim K; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
    Endocr J; 2019 Oct; 66(10):881-889. PubMed ID: 31189770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical outcomes of parathyroidectomy for secondary hyperparathyroidism resistant to calcimimetic treatment: A retrospective single-center cohort study.
    Okada M; Tominaga Y; Ichimori T; Tomosugi T; Hiramitsu T; Tsuzuki T
    Ther Apher Dial; 2021 Apr; 25(2):188-196. PubMed ID: 32592622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis.
    McManus C; Oh A; Lee JA; Hur C; Kuo JH
    Surgery; 2021 Jan; 169(1):94-101. PubMed ID: 32732069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Universal Insurance and Access to Care Influence Disparities in Outcomes for Pediatric Patients with Osteomyelitis?
    Young JD; Dee EC; Levine A; Sturgeon DJ; Koehlmoos TP; Schoenfeld AJ
    Clin Orthop Relat Res; 2020 Jul; 478(7):1432-1439. PubMed ID: 31725027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients.
    Alvarado L; Sharma N; Lerma R; Dwivedi A; Ahmad A; Hechanova A; Payan-Schober F; Nwosu A; Alkhalili E
    World J Surg; 2022 Apr; 46(4):813-819. PubMed ID: 35022799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical parathyroidectomy versus cinacalcet therapy: in the management of secondary hyperparathyroidism.
    Ghani A; Baxter P
    Otolaryngol Head Neck Surg; 2012 Feb; 146(2):220-5. PubMed ID: 22075073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes.
    Anderson K; Ruel E; Adam MA; Thomas S; Youngwirth L; Stang MT; Scheri RP; Roman SA; Sosa JA
    Am J Surg; 2017 Nov; 214(5):914-919. PubMed ID: 28736060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.